<prompt> Reslizumab used in bronchial asthma is a monoclonal antibody againstIL-2IL-3IL-4IL-5  <response>: Mepolizumab Reslizumab are monoclonal antibodies against IL-5 used in bronchial asthma, which act by inhibiting recruitment of eosinophils. 